Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics granted inducement equity awards covering 178,580 shares to 33 new employees on October 10, 2026, under Nasdaq Listing Rule 5635(c)(4). The grants consist of options to purchase 36,000 shares at $52.02 per share plus RSUs covering 142,580 shares, each vesting over four years.
Key figures
- New employees
- 33
- Inducement rsu shares
- 142580
- Option exercise price
- 52.02
- Inducement option shares
- 36000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.